Kevin J Lynch

USPTO Granted Patents = 7 (Patent Applications = 1)

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 22(Granted Patents)

Company Filing History:

5 out of 207

Aventis Pharmaceuticals Inc.

patents

2 out of 4,177

Abbott Laboratories Corporation

patents

1 out of 2,595

University of Pennsylvania

patents

where one patent can have more than one assignee

Years Active: 2001-2013

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8343494 - Antibodies against LLG polypeptides of the triacylglycerol lipase family (2013-01-01),

2. 7579447 - Antibodies against LLG polypeptides of the triacylglycerol lipase family (2009-08-25),

3. 7056720 - LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies (2006-06-06),

4. 7008776 - Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol (2006-03-07),

5. 6395530 - LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies (2002-05-28),

6. 6242216 - Nucleic acids encoding a functional human purinoreceptor P2X2 and P2X4, and methods of production and use thereof (2001-06-05),

7. 6214581 - Nucleic acids encoding a functional human purinoreceptor P2X3 and P2X6, and methods of production and use thereof (2001-04-10),

Title: Kevin J Lynch: Innovator in Lipid Metabolism Research

Introduction

Kevin J Lynch is a notable inventor based in Gurnee, Illinois, with a significant contribution to the field of lipid metabolism. He holds a total of seven patents, showcasing his innovative approach to biochemistry and molecular biology. His work primarily focuses on the development of antibodies and methods related to the triacylglycerol lipase family.

Latest Patents

Among his latest patents, Kevin has developed antibodies against LLG polypeptides of the triacylglycerol lipase family. These patents include nucleic acids encoding said polypeptides, antisense sequences, and antibodies to these polypeptides. Additionally, he has disclosed methods for the preparation of these polypeptides in a recombinant system. His research also explores the use of these polypeptides to screen for agonists and antagonists, as well as methods and compositions for treating disorders of lipid metabolism.

Career Highlights

Throughout his career, Kevin has worked with prominent companies in the pharmaceutical industry, including Aventis Pharmaceuticals Inc. and Abbott Laboratories Corporation. His experience in these organizations has allowed him to contribute significantly to advancements in medical research and therapeutic development.

Collaborations

Kevin has collaborated with several professionals in his field, including Michael C Jaye and Kim-Anh Thi Doan. These collaborations have further enriched his research and innovation efforts.

Conclusion

Kevin J Lynch is a distinguished inventor whose work in lipid metabolism has led to significant advancements in the field. His patents and collaborations reflect his commitment to improving health outcomes through innovative research.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.